While open innovation may be seen as a way of cutting costs by shutting down in-house R&D in favour of...
OPINION
Experts Point of View
Spanish 3P Biopharmaceuticals has shown tremendous growth, at least 10 per cent above market growth rate in...
A newly forming industry association warns the European Commission not to block patients’ access to the...
The European biotech sector is flourishing – rising stock prices, big partnering deals, and some major M&A....
Medical cannabis has become one of the most important economic topics in recent years! But, what makes this...
In 2019, a new AMR accelerator kicked off under the aegis of the Innovative Medicines Initiative as a...
Share
